Innophos Holdings, Inc. (IPHS) Lifted to “Buy” at Sidoti

Innophos Holdings, Inc. (IPHS) Lifted to “Buy” at Sidoti

Separately, Zacks Investment Research cut Innophos Holdings from a hold rating to a strong sell rating in a report on Thursday, January 26th.

Sidoti upgraded shares of Innophos Holdings, Inc. (NASDAQ:IPHS) from a neutral rating to a buy rating in a research note published on Friday morning. The analysts noted that the move was a valuation call.

Shares of Innophos Holdings (NASDAQ:IPHS) opened at 43.28 on Friday. The company has a market cap of $838.59 million, a P/E ratio of 18.58 and a beta of 0.75. The firm has a 50-day moving average price of $44.76 and a 200-day moving average price of $50.25. Innophos Holdings has a 1-year low of $37.02 and a 1-year high of $58.22.

Innophos Holdings (NASDAQ:IPHS) last announced its earnings results on Monday, May 1st. The specialty chemicals company reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.52 by $0.07. Innophos Holdings had a return on equity of 10.36% and a net margin of 4.66%. The business had revenue of $165.94 million during the quarter, compared to analysts’ expectations of $168.11 million. During the same quarter in the prior year, the firm earned $0.66 earnings per share. The business’s revenue was down 12.5% compared to the same quarter last year. On average, equities analysts expect that Innophos Holdings will post $2.49 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, June 2nd. Shareholders of record on Friday, May 19th will be issued a dividend of $0.48 per share. The ex-dividend date of this dividend is Wednesday, May 17th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 4.44%. Innophos Holdings’s payout ratio is currently 111.63%.

Several institutional investors have recently made changes to their positions in the stock. Caxton Associates LP purchased a new position in shares of Innophos Holdings during the first quarter worth approximately $400,000. Barings LLC purchased a new position in shares of Innophos Holdings during the first quarter worth approximately $200,000. Paloma Partners Management Co boosted its position in shares of Innophos Holdings by 25.5% in the first quarter. Paloma Partners Management Co now owns 14,687 shares of the specialty chemicals company’s stock worth $793,000 after buying an additional 2,987 shares during the last quarter. AQR Capital Management LLC boosted its position in shares of Innophos Holdings by 37.0% in the first quarter. AQR Capital Management LLC now owns 168,630 shares of the specialty chemicals company’s stock worth $9,100,000 after buying an additional 45,509 shares during the last quarter. Finally, Gotham Asset Management LLC boosted its position in shares of Innophos Holdings by 3.6% in the first quarter. Gotham Asset Management LLC now owns 131,122 shares of the specialty chemicals company’s stock worth $7,077,000 after buying an additional 4,511 shares during the last quarter. 92.61% of the stock is owned by institutional investors and hedge funds.

About Innophos Holdings

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:IPHS”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Related posts

Leave a Comment